Cargando…

Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of Life

Polycystic liver disease (PLD) is a genetic disorder in which patients suffer from progressive development of multiple (>10) hepatic cysts. Most patients remain asymptomatic during the course of their disease. However, a minority of PLD patients suffer from symptoms caused by hepatomegaly leading...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duijzer, Renée, Barten, Thijs R.M., Staring, Christian B., Drenth, Joost P.H., Gevers, Tom J.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Clinical Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432811/ https://www.ncbi.nlm.nih.gov/pubmed/35997709 http://dx.doi.org/10.1097/MCG.0000000000001749

Ejemplares similares

Impact of liver volume on polycystic liver disease-related symptoms and quality of life
por: Neijenhuis, Myrte K, et al.
Publicado: (2017)

Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease
por: Gevers, Tom JG, et al.
Publicado: (2012)

Patient reported outcome measure thresholds: The next step in the management of polycystic liver disease
por: Duijzer, Renée, et al.
Publicado: (2023)

Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease
por: Boerrigter, Melissa M., et al.
Publicado: (2023)

Abdominal wall hernia is a frequent complication of polycystic liver disease and associated with hepatomegaly
por: Barten, Thijs R. M., et al.
Publicado: (2022)

Estrogen‐Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal Patients
por: van Aerts, René M.M., et al.
Publicado: (2019)

Estrogens in polycystic liver disease: A target for future therapies?
por: Aapkes, Sophie E., et al.
Publicado: (2021)

Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management
por: Cnossen, Wybrich R, et al.
Publicado: (2014)

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues
por: van Aerts, René M. M., et al.
Publicado: (2018)

The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression
por: Neijenhuis, Myrte K., et al.
Publicado: (2017)

Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial
por: Wijnands, Titus FM, et al.
Publicado: (2015)

Everolimus and long acting octreotide as a volume reducing treatment of polycystic livers (ELATE): study protocol for a randomized controlled trial
por: Chrispijn, Melissa, et al.
Publicado: (2011)

Tamoxifen for the treatment of polycystic liver disease: A case report
por: Aapkes, Sophie E., et al.
Publicado: (2021)

Validation of a semi-automatic method to measure total liver volumes in polycystic liver disease on computed tomography — high speed and accuracy
por: Aapkes, Sophie E., et al.
Publicado: (2023)

Management of portal hypertension and ascites in polycystic liver disease
por: Bernts, Lucas H. P., et al.
Publicado: (2019)

Health-related quality of life in autoimmune hepatitis
por: Snijders, Romée JALM, et al.
Publicado: (2021)

A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?
por: Betzel, Bark, et al.
Publicado: (2014)

Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts
por: Wijnands, Titus FM, et al.
Publicado: (2018)

Loss of Heterozygosity Is Present in SEC63 Germline Carriers with Polycystic Liver Disease
por: Janssen, Manoe J., et al.
Publicado: (2012)

Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts
por: Neijenhuis, Myrte K., et al.
Publicado: (2018)

Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE‐LIVER online survey
por: Wunsch, Ewa, et al.
Publicado: (2022)

Novel GANAB variants associated with polycystic liver disease
por: van de Laarschot, Liyanne F. M., et al.
Publicado: (2020)

The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease
por: Matsuura, Ryo, et al.
Publicado: (2016)

Gastroparesis in patients with inactive Crohn's disease: a case series
por: Kristinsson, Jón O, et al.
Publicado: (2007)

Novel α-1,3-Glucosyltransferase Variants and Their Broad Clinical Polycystic Liver Disease Spectrum
por: Boerrigter, Melissa M., et al.
Publicado: (2023)

Assessment of symptoms of urinary incontinence in women with polycystic ovary syndrome
por: Montezuma, Thais, et al.
Publicado: (2011)

A TGFβ-ECM-Integrin signalling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease
por: Waddell, Scott H, et al.
Publicado: (2023)

Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models
por: Lee-Law, Pui Y., et al.
Publicado: (2020)

Loss to follow‐up in the hepatitis C care cascade: A substantial problem but opportunity for micro‐elimination
por: van Dijk, Marleen, et al.
Publicado: (2020)

Fenestration of liver cysts in polycystic liver disease to improve quality of life: a case report and literature review
por: Jung, Dong-Hwan, et al.
Publicado: (2015)

Prevalence of genetic polymorphisms in the promoter region of the alpha-1 antitrypsin (SERPINA1) gene in chronic liver disease: a case control study
por: Kok, Karin F, et al.
Publicado: (2010)

The impact of exercise perceptions and depressive symptoms on polycystic ovary syndrome–specific health-related quality of life
por: Wright, Pamela J, et al.
Publicado: (2021)

Decreased health-related quality of life in angiodysplasia patients: A cross-sectional cohort
por: Grooteman, Karina V., et al.
Publicado: (2017)

Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Kim, Yaerim, et al.
Publicado: (2023)

Health-related quality of life and its relationship with clinical symptoms among Iranian patients with polycystic ovarian syndrome
por: Bazarganipour, Fatemeh, et al.
Publicado: (2013)

Determinants of Quality of Life and Satisfaction with Life in Women with Polycystic Ovary Syndrome
por: Rzońca, Ewa, et al.
Publicado: (2018)

Impact of Sex on the Nonmotor Symptoms and the Health-Related Quality of Life in Parkinson's Disease
por: Kovács, Márton, et al.
Publicado: (2016)

Patient-Reported Gastrointestinal Symptoms and the Association With Quality of Life Following Kidney Transplantation
por: Chan, Samuel, et al.
Publicado: (2020)

Clinical management of autoimmune hepatitis
por: Pape, Simon, et al.
Publicado: (2019)

The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials
por: Garofalo, Carlo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_19ai01ldl3vjliirhr9rri5kk7